XENPOZYME
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for XENPOZYME, covering 2022-08-31 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety and Tolerability of Olipudase Alfa in Pediatric and Adult Participants With Acid Sphingomyelinase Deficiency (ASMD) Who Completed the DFI12712 or the LTS13632 Study in France [Phase 2]